Amicus Therapeutics Archives

Press ESC key to close search

Hayfin Capital Management Supplies $400MM Debt Financing to Amicus Therapeutics

Hayfin Capital Management executed a $400 million credit facility for Amicus Therapeutics, a biotechnology company focused on discovering, developing and delivering novel medicines for rare diseases.

BioPharma Credit Supports Amicas Acquisition of 10 Gene Therapies

Amicus Therapeutics signed an agreement to obtain worldwide development and commercial rights for 10 gene therapy programs. BioPharma Credit provided a $150 million term loan to support the purchase.

September 24, 2018 Amicus Therapeutics | Biopharma Credit | Celenex Amanda Koprowski

MidCap, Oxford and SVB Complete Amicus Therapeutics Debt Financing

Amicus Therapeutics announced it completed a $25 million, long-term debt financing with a lending syndicate consisting of MidCap Financial, Oxford Finance and Silicon Valley Bank.

December 31, 2013 Amicus Therapeutics | MidCap Financial | Oxford Finance | Silicon Valley Bank ABF Journal

<img width="200" src="https://www.abfjournal.com/wp-content/uploads/2020/02/abfj-logo-web-header1-blue.png" alt="ABFJournal" />

Tag Archives: Amicus Therapeutics

Hayfin Capital Management Supplies $400MM Debt Financing to Amicus Therapeutics

BioPharma Credit Supports Amicas Acquisition of 10 Gene Therapies

MidCap, Oxford and SVB Complete Amicus Therapeutics Debt Financing